SCHEMBL12411675

SCHEMBL12411675

[C-]#[N+]c1cc2c(Oc3ccc(NC(=O)Nc4cc(C)on4)cc3)ccnc2cc1OCCOC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 4/20 0.56
KDR P35968 13/20 0.55
PDGFRA P16234 12/20 0.55
FLT1 P17948 2/20 0.55
EPHB2 P29323 2/20 0.55
FLT4 P35916 2/20 0.55
MET P08581 2/20 0.55
KIT P10721 2/20 0.55
RIPK2 O43353 1/20 0.55
STK10 O94804 1/20 0.55
ABL1 P00519 1/20 0.55
LCK P06239 1/20 0.55
LYN P07948 1/20 0.55
RET P07949 1/20 0.55
PDGFRB P09619 1/20 0.55
BCR P11274 1/20 0.55
FGFR1 P11362 1/20 0.55
SRC P12931 1/20 0.55
MAPK3 P27361 1/20 0.55
HTR2A P28223 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12411468 0.88 PDGFRA (0.67) KDRPDGFRAMETKITHDAC1
SCHEMBL12411674 0.88 PDGFRA (0.52) FLT3KDRPDGFRAMETKIT
SCHEMBL12411333 0.88 PDGFRA (0.58) KDRPDGFRAMETAXLHDAC1
SCHEMBL12411459 0.88 PDGFRA (0.67) KDRPDGFRAMETKITAXL
SCHEMBL12411495 0.88 PDGFRA (0.58) KDRPDGFRAMETAXLHDAC1
SCHEMBL12411330 0.87 PDGFRA (0.57) KDRPDGFRAMETKITAXL
SCHEMBL12411329 0.87 PDGFRA (0.67) FLT3KDRPDGFRAFLT1FLT4
SCHEMBL1898499 0.86 KDR (0.55) FLT3KDRPDGFRAFLT1EPHB2
SCHEMBL12411974 0.84 MET (0.55) KDRPDGFRAMETKITAXL
SCHEMBL12411498 0.84 PDGFRA (0.58) KDRPDGFRAMETHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973160-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-07-05 US disclosed
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-05 US disclosed
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed
US-7253286-B2 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI CO., LTD (JP) 2007-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives GNG2, GCG, FRG1 FLT3 1153/4885KDR 2687/4885PDGFRA 3131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.